The largest database of trusted experimental protocols

Performance high sensitivity human cytokine

Manufactured by R&D Systems
Sourced in United States

The Performance High Sensitivity Human Cytokine is a laboratory equipment designed for the detection and quantification of various cytokines in human samples. It utilizes a highly sensitive immunoassay technology to provide accurate and reliable measurements.

Automatically generated - may contain errors

7 protocols using performance high sensitivity human cytokine

1

Plasma Cytokine Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected in pre-chilled EDTA tubes. After collection, the samples were centrifuged at 4°C, plasma was harvested into multiple aliquots, and then stored in a −70°C freezer until the completion of the study.
Plasma TNF-α and IL-6 concentrations (assay ranges 0.8–3100 pg/mL and 0.2–3800 pg/mL, respectively) were determined using a Bio-Plex 200 (Luminex) Instrument, and a high sensitivity bead-based multiplex immunoassay (Performance High Sensitivity Human Cytokine, R& D Systems, Minneapolis, MN), as previously described (Moieni et al., 2015a (link); Moieni et al., 2015b (link)). All plasma samples from each subject (baseline and all subsequent time points) were assayed on the same 96-well plate; every subject demonstrated the expected profile of change of cytokine concentrations over time, based on previous studies (Eisenberger et al., 2010 (link); Eisenberger et al., 2009 (link)). The mean intra-assay CV% of the standards was < 8% for TNF-α and IL-6; the inter-assay CV% of an internal laboratory quality control sample was < 13% for both analytes.
+ Open protocol
+ Expand
2

Plasma Cytokine Profiling Methodology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma tumor necrosis factor (TNF)-α and interleukin (IL)-6 concentrations were determined using a high sensitivity bead-based multiplex immunoassay (Performance High Sensitivity Human Cytokine, R&D Systems, Minneapolis, MN, United States), as previously described (Moieni et al., 2015a (link),b (link),c (link)). The full cytokine profile for participants from this exact study is available in other publications (Moieni et al., 2015b (link),c (link)).
+ Open protocol
+ Expand
3

Multiplex Cytokine Profiling in Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral inflammation was assessed at each time point as previously described [24 ]. In brief, plasma concentrations of interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α were measured using a Bio-Plex 200 (Luminex Corporation, Austin, TX) instrument and a high-sensitivity multiplex immunoassay (Performance High Sensitivity Human Cytokine, R&D Systems, Minneapolis, MN). Data acquisition and analyses were performed with Bio-Plex software v4.1, and a 5-parameter logistic curve fit. Multiplex assays, which are shown to have high intra-assay reproducibility [28 ], were performed on samples diluted twofold as per the manufacturer’s protocol. C-reactive protein (CRP) was measured using Human CRP Quantikine ELISA (R&D Systems), also as per manufacturer protocols.
+ Open protocol
+ Expand
4

Quantification of IL-6 and TNF-α

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of IL-6 and TNF-α were quantified by high sensitivity bead-based multiplex (Luminex) immunoassays (Performance High Sensitivity Human Cytokine, R&D Systems, Minneapolis, MN, USA), as previously described.21 (link)
+ Open protocol
+ Expand
5

Cytokine Quantification in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) were quantified by high sensitivity bead-based multiplex (Luminex) immunoassays (Performance High Sensitivity Human Cytokine, R&D Systems, Minneapolis, MN, USA), as previously described (Moieni et al., 2015a (link); Moieni et al., 2015b (link)). The lower limits of detection for IL-6 and TNF-α were 0.2 and 0.8 pg/ml, respectively. TNF-α was detectable in 100% of samples. For the small proportion of samples with IL-6 below the lower limit of detection (<1%), the values were treated as missing. The mean intra-assay CV% of the standards was <8% for IL-6 and TNF-a; the interassay CV% of an internal laboratory quality control sample was <3% for both analytes. In the current study, analyses focused only T0, T2, and T6 time points, given that these are the time points for which KYN pathway data were available for comparison.
+ Open protocol
+ Expand
6

Cytokine Profiling from Frozen Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected in prechilled EDTA tubes. After collection, the samples were centrifuged at 4 °C, plasma was harvested into multiple aliquots, and then stored at − 70 °C until immunoassays were performed.
Data for baseline (T0) levels of IL-8, IL-6, and TNF-α were obtained by high sensitivity bead-based multiplex (Luminex) immunoassays (Performance High Sensitivity Human Cytokine, R&D Systems, Minneapolis, MN, USA), as previously described15 (link). Due to the strength of the original study design, which utilized up to seven repeated measures of cytokine values to profile inflammatory cytokine responses for each subject, the plasma sample from each time point was evaluated in a single determination. The average intra-assay CV% for standards was 4.3, 4.4, and 5.3 for IL-6, IL-8, and TNF-α, respectively; the inter-assay CV% of an internal laboratory quality control sample was < 13.5% for all three analytes. The lower limit of detection for IL-8 was 0.1 and values lower than this limit were entered as 0.05 (1/2 the lower limit); n = 6 samples).
+ Open protocol
+ Expand
7

Plasma Cytokine Profiling in Clinical Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected in pre-chilled EDTA tubes. After collection, the samples were centrifuged at 4°C, plasma was harvested into multiple aliquots, and then stored in a −70°C freezer until the completion of the study.
Plasma tumor necrosis factor (TNF)-α and interleukin (IL)-6 concentrations (assay ranges 0.8–3100 pg/mL and 0.2–3800 pg/mL, respectively) were determined using a Bio-Plex 200 (Luminex) Instrument, and a high sensitivity bead-based multiplex immunoassay (Performance High Sensitivity Human Cytokine, R& D Systems, Minneapolis, MN), as previously described (4 (link), 27 (link), 31 (link)). The full cytokine profile for participants from this exact study are available in other publications (4 (link), 27 (link)). All plasma samples from each subject (baseline and all subsequent time points) were assayed on the same 96-well plate; every subject demonstrated the expected profile of cytokine concentrations over time, based on previous studies (7 (link), 35 (link)). The mean intra-assay CV% of the standards was < 8% for TNF-α and IL-6; the inter-assay CV% of an internal laboratory quality control sample was < 13% for both analytes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!